Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia. 1974

E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D005260 Female Females
D005470 Fluorometry An analytical method for detecting and measuring FLUORESCENCE in compounds or targets such as cells, proteins, or nucleotides, or targets previously labeled with FLUORESCENCE AGENTS. Fluorimetry,Fluorometric Analysis,Analysis, Fluorometric
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes

Related Publications

E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer
January 1988, Pharmacology,
E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer
January 1981, European journal of drug metabolism and pharmacokinetics,
E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer
September 1989, Calcified tissue international,
E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer
August 1988, Calcified tissue international,
E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer
December 1967, Acta physiologica et pharmacologica Neerlandica,
E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer
January 1982, Annals of biomedical engineering,
E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer
June 2020, Chemical communications (Cambridge, England),
E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer
January 1974, European journal of clinical pharmacology,
E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer
February 1979, Experientia,
E E Ohnhaus, and E Nüesch, and J Meier, and F Kalberer
January 1998, European journal of drug metabolism and pharmacokinetics,
Copied contents to your clipboard!